Complex Coronary Artery Disease
Clinical trial pipeline · Data from ClinicalTrials.gov
See which Complex Coronary Artery Disease trials you may qualify forClinical trial pipeline · Data from ClinicalTrials.gov
See which Complex Coronary Artery Disease trials you may qualify forCoronary artery disease remains a leading cause of mortality worldwide and is commonly treated with percutaneous coronary intervention (PCI). Typically, PCI is…
This study will demonstrate the safety and effectiveness of the Edwards Lifesciences SAPIEN 3/SAPIEN 3 Ultra RESILIA Transcatheter Heart Valve (THV) Systems in…
This study is a prospective, open label, two-arm, randomized multicenter trial to evaluate the efficacy and safety of aspirin plus prasugrel as compared with as…
If there is a narrowing or blockage in the coronary arteries of the heart, the cardiologist may choose to treat this blockage. This is called percutaneous coron…
What is this study about? This study will test whether adding sotatercept to usual medicines for pulmonary arterial hypertension (PAH) can help adults who have…
The goal of this clinical trial is to evaluate the feasibility, effectiveness, and safety of pre-emptive left atrial veno-arterial extracorporeal membrane oxyge…
Congenital heart disease is the most common congenital anomaly. The life expectancy of children with congenital heart disease has increased considerably in rece…
This study is a prospective, multicenter, observational registry study (based on real-world data). Participants who meet all inclusion and exclusion criteria wi…
The aim of this research is to study the prognostic role of a selected combination of cytokines and adipokines in patients with myocardial infarction, as well a…